Merck KGaA (ETR:MRK - Get Free Report) rose 2.2% on Wednesday . The stock traded as high as €112.40 ($132.24) and last traded at €112.40 ($132.24). Approximately 308,870 shares traded hands during trading, The stock had previously closed at €110.00 ($129.41).
Merck KGaA Trading Down 1.7%
The business has a 50 day simple moving average of €116.50 and a 200-day simple moving average of €128.02. The stock has a market capitalization of $49.32 billion, a price-to-earnings ratio of 18.19, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
